APOA1 and cancer: In light of the pathogenesis of cancer development, the HDL‐ApoA1 axis has been postulated to potentially modulate proliferative and inflammatory pathways via its immunomodulatory, antioxidative, antiapoptotic, and antiinflammatory properties.43, 44